Literature DB >> 19066229

NLRP7 mutations in women with diploid androgenetic and triploid moles: a proposed mechanism for mole formation.

Catherine Deveault1, Jian Hua Qian, Wafaa Chebaro, Asangla Ao, Lucy Gilbert, Amira Mehio, Rabia Khan, Seang Lin Tan, Anita Wischmeijer, Philippe Coullin, Xing Xie, Rima Slim.   

Abstract

Hydatidiform mole is an aberrant pregnancy with abnormal embryonic development and hydropic placental villi. Common moles are sporadic, not recurrent and affect one in every 1500 pregnancies in Western societies. Approximately, half of common moles are complete and mostly diploid androgenetic, whereas the remaining are partial and mostly triploid diandric. NLRP7 has been found to be responsible for a recurrent form of molar pregnancies. Recently, we showed that patients with NLRP7 mutations have an impaired inflammatory response to various stimuli. To date, molar tissues analyzed from patients with NLRP7 mutations have been found to be diploid and biparental. In this study, we report 10 new non-synonymous variants and one stop codon found in patients and not in controls. We demonstrate the presence of different types of moles, diploid biparental, diploid androgenetic, triploid and tetraploid conceptions, in patients with NLRP7 variants. We document in vitro and in vivo early embryo cleavage abnormalities in three patients. We propose a two-hit mechanism at the origin of androgenetic moles. This mechanism consists of variable degrees of early embryo cleavage abnormalities leading to chaotic mosaic aneuploidies, with haploid, diploid, triploid and tetraploid blastomeres. Surviving embryonic cells that reach implantation are then subject to the maternal immune response. Because of the patients' impaired inflammatory response, androgenetic cells, which are complete allograft, are able to grow and proliferate. In women with normal immune system, chaotic mosaic aneuploidies may also occur during early cleavage, however, androgenetic cells would die after implantation or stay undetected, confined to a small portion of the placenta.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19066229     DOI: 10.1093/hmg/ddn418

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  27 in total

1.  Three-dimensional structure of the NLRP7 pyrin domain: insight into pyrin-pyrin-mediated effector domain signaling in innate immunity.

Authors:  Anderson S Pinheiro; Martina Proell; Clarissa Eibl; Rebecca Page; Robert Schwarzenbacher; Wolfgang Peti
Journal:  J Biol Chem       Date:  2010-06-11       Impact factor: 5.157

2.  Recurrent triploid and dispermic conceptions in patients with NLRP7 mutations.

Authors:  R Slim; A Ao; U Surti; L Zhang; L Hoffner; J Arseneau; A Cheung; W Chebaro; A Wischmeijer
Journal:  Placenta       Date:  2011-03-21       Impact factor: 3.481

3.  A strong founder effect for two NLRP7 mutations in the Indian population: an intriguing observation.

Authors:  R Slim; R Bagga; W Chebaro; R Srinivasan; N Agarwal
Journal:  Clin Genet       Date:  2009-07-24       Impact factor: 4.438

Review 4.  The inflammasomes in health and disease: from genetics to molecular mechanisms of autoinflammation and beyond.

Authors:  Cristina Conforti-Andreoni; Paola Ricciardi-Castagnoli; Alessandra Mortellaro
Journal:  Cell Mol Immunol       Date:  2011-01-24       Impact factor: 11.530

5.  Differential expression of E-cadherin, β-catenin, and Lewis x between invasive hydatidiform moles and post-molar choriocarcinomas.

Authors:  Jean-Jacques Candelier; Lucien Frappart; Ange Lucien Diatta; Tarik Yadaden; Mamadou-Lamine Cissé; Jean-Marie Afoutou; Jean-Yves Picard; Benoît Mennesson; Rima Slim; Karim Si-Tayeb; Philippe Coullin
Journal:  Virchows Arch       Date:  2013-05-17       Impact factor: 4.064

6.  Report of four new patients with protein-truncating mutations in C6orf221/KHDC3L and colocalization with NLRP7.

Authors:  Ramesh Reddy; Elie Akoury; Ngoc Minh Phuong Nguyen; Omar A Abdul-Rahman; Christine Dery; Neerja Gupta; William P Daley; Asangla Ao; Hanene Landolsi; Rosemary Ann Fisher; Isabelle Touitou; Rima Slim
Journal:  Eur J Hum Genet       Date:  2012-12-12       Impact factor: 4.246

Review 7.  Inflammasomes and their activation.

Authors:  Sonal Khare; Nancy Luc; Andrea Dorfleutner; Christian Stehlik
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

8.  Maternal heterozygous NLRP7 variant results in recurrent reproductive failure and imprinting disturbances in the offspring.

Authors:  Lukas Soellner; Matthias Begemann; Franziska Degenhardt; Annegret Geipel; Thomas Eggermann; Elisabeth Mangold
Journal:  Eur J Hum Genet       Date:  2017-05-31       Impact factor: 4.246

9.  Altered p16 and Bcl-2 expression reflects pathologic development in hydatidiform moles and choriocarcinoma.

Authors:  Jean-Jacques Candelier; Lucien Frappart; Tarik Yadaden; Henriette Poaty; Jean-Yves Picard; Sophie Prévot; Philippe Coullin
Journal:  Pathol Oncol Res       Date:  2012-10-13       Impact factor: 3.201

10.  Abnormal processing of IL-1β in NLRP7-mutated monocytes in hydatidiform mole patients.

Authors:  P Zhang; X Zhu; X Yu; B Huang; T Jiang; X Zhang; H Yang; J Qian
Journal:  Clin Exp Immunol       Date:  2020-07-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.